VERITONE INC (VERI)

US92347M1009 - Common Stock

3.6  +0.07 (+1.98%)

Fundamental Rating

1

VERI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. VERI has a bad profitability rating. Also its financial health evaluation is rather negative. VERI is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year VERI has reported negative net income.
VERI had a negative operating cash flow in the past year.
VERI had negative earnings in each of the past 5 years.
In multiple years VERI reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of VERI (-24.43%) is worse than 73.63% of its industry peers.
Industry RankSector Rank
ROA -24.43%
ROE N/A
ROIC N/A
ROA(3y)-11.37%
ROA(5y)-23.66%
ROE(3y)-86.84%
ROE(5y)-89.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

VERI's Gross Margin of 75.63% is fine compared to the rest of the industry. VERI outperforms 67.77% of its industry peers.
In the last couple of years the Gross Margin of VERI has remained more or less at the same level.
VERI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.26%
GM growth 5Y0.4%

0

2. Health

2.1 Basic Checks

VERI does not have a ROIC to compare to the WACC, probably because it is not profitable.
VERI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VERI has more shares outstanding
The debt/assets ratio for VERI is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -2.70, we must say that VERI is in the distress zone and has some risk of bankruptcy.
VERI's Altman-Z score of -2.70 is on the low side compared to the rest of the industry. VERI is outperformed by 79.49% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.7
ROIC/WACCN/A
WACC8.74%

2.3 Liquidity

A Current Ratio of 0.66 indicates that VERI may have some problems paying its short term obligations.
VERI has a worse Current ratio (0.66) than 89.01% of its industry peers.
A Quick Ratio of 0.66 indicates that VERI may have some problems paying its short term obligations.
VERI has a Quick ratio of 0.66. This is amonst the worse of the industry: VERI underperforms 88.28% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66

3

3. Growth

3.1 Past

VERI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.19%.
The Revenue has decreased by -0.88% in the past year.
The Revenue has been growing by 36.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.52%
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y30.27%
Revenue growth 5Y36.42%
Sales Q2Q%-37.41%

3.2 Future

VERI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.62% yearly.
The Revenue is expected to decrease by -2.55% on average over the next years.
EPS Next Y25.06%
EPS Next 2Y20.35%
EPS Next 3Y22.62%
EPS Next 5YN/A
Revenue Next Year-15.93%
Revenue Next 2Y-9.06%
Revenue Next 3Y-2.55%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

VERI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VERI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as VERI's earnings are expected to grow with 22.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.35%
EPS Next 3Y22.62%

0

5. Dividend

5.1 Amount

VERI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VERITONE INC

NASDAQ:VERI (1/6/2025, 4:00:39 PM)

3.6

+0.07 (+1.98%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners29.47%
Inst Owner Change0%
Ins Owners13.44%
Ins Owner Change-19.74%
Market Cap137.92M
Analysts43.33
Price Target3.57 (-0.83%)
Short Float %14.84%
Short Ratio4.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-424.51%
Min EPS beat(2)-831.37%
Max EPS beat(2)-17.65%
EPS beat(4)1
Avg EPS beat(4)-213.35%
Min EPS beat(4)-831.37%
Max EPS beat(4)1.96%
EPS beat(8)1
Avg EPS beat(8)-117.97%
EPS beat(12)3
Avg EPS beat(12)-84.8%
EPS beat(16)7
Avg EPS beat(16)-58.67%
Revenue beat(2)0
Avg Revenue beat(2)-22.55%
Min Revenue beat(2)-43.12%
Max Revenue beat(2)-1.99%
Revenue beat(4)1
Avg Revenue beat(4)-11.22%
Min Revenue beat(4)-43.12%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-7.35%
Revenue beat(12)4
Avg Revenue beat(12)-3.59%
Revenue beat(16)7
Avg Revenue beat(16)-2.4%
PT rev (1m)0%
PT rev (3m)-12.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-580%
EPS NY rev (1m)-105.71%
EPS NY rev (3m)-105.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-41.1%
Revenue NY rev (1m)-22.47%
Revenue NY rev (3m)-22.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.73
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-1.53
FCFYN/A
OCF(TTM)-1.37
OCFYN/A
SpS3.55
BVpS-0.66
TBVpS-3.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.43%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.63%
FCFM N/A
ROA(3y)-11.37%
ROA(5y)-23.66%
ROE(3y)-86.84%
ROE(5y)-89.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.26%
GM growth 5Y0.4%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.44%
Cap/Sales 4.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z -2.7
F-Score4
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)17.37%
Cap/Depr(5y)13.57%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.52%
EPS Next Y25.06%
EPS Next 2Y20.35%
EPS Next 3Y22.62%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y30.27%
Revenue growth 5Y36.42%
Sales Q2Q%-37.41%
Revenue Next Year-15.93%
Revenue Next 2Y-9.06%
Revenue Next 3Y-2.55%
Revenue Next 5YN/A
EBIT growth 1Y-15.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.89%
EBIT Next 3Y32.91%
EBIT Next 5YN/A
FCF growth 1Y-222.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-278.76%
OCF growth 3YN/A
OCF growth 5YN/A